Literature DB >> 12854178

Fatty metamorphosis of the liver in patients with breast cancer: possible associated factors.

Cheng-Hsin Chu1, Shee-Chan Lin, Shou-Chuan Shih, Chin-Roa Kao, Sun-Yen Chou.   

Abstract

AIM: To investigate the relationship between breast cancer and fatty liver in Chinese patients.
METHODS: The study group consisted of 217 patients with newly diagnosed breast cancers and the control group of 182 subjects undergoing routine health examination in the same hospital. All subjects were female and the groups were matched for date of study. Ultrasound scanning was performed by the same operator using a 3.5 mHz transducer. Steatosis of the liver was diagnosed based on the criteria of Saverymuttu et al. Clinical variables were statistically analyzed.
RESULTS: Fatty liver was diagnosed in 98 patients of the study group and 37 patients of the control group, a significant difference was found in incidence (98/217, 45.2 % and 37/182, 20.3 %; P<0.0001). On univariate analysis, fatty liver in breast cancer patients was associated with overweight, hyperlipidemia, and hepatitis. On multivariate analysis in the same patients, obesity and hyperlipidemia were significantly associated with fatty liver.
CONCLUSION: The cause of fatty liver in women with breast cancer may be multifactorial. The present study confirms its link with overweight and hyperlipidemia.

Entities:  

Mesh:

Year:  2003        PMID: 12854178      PMCID: PMC4615519          DOI: 10.3748/wjg.v9.i7.1618

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  21 in total

1.  Tamoxifen-induced fatty liver in patients with breast cancer.

Authors:  Y Ogawa; Y Murata; A Nishioka; T Inomata; S Yoshida
Journal:  Lancet       Date:  1998-03-07       Impact factor: 79.321

2.  Relationships between tamoxifen use, liver fat and body fat distribution in women with breast cancer.

Authors:  M C Nguyen; R B Stewart; M A Banerji; D H Gordon; J G Kral
Journal:  Int J Obes Relat Metab Disord       Date:  2001-02

3.  Fatty metamorphosis of the liver in morbid obesity.

Authors:  W H Kern; A H Heger; J H Payne; L T DeWind
Journal:  Arch Pathol       Date:  1973-11

4.  Epidemiologic characteristics of cancer of the breast in Taiwan.

Authors:  T M Lin; K P Chen; B MacMahon
Journal:  Cancer       Date:  1971-06       Impact factor: 6.860

5.  Epidemiology of breast cancer with special reference to the role of diet.

Authors:  T Hirayama
Journal:  Prev Med       Date:  1978-06       Impact factor: 4.018

6.  The accuracy of ultrasound in the detection of fatty infiltration of the liver.

Authors:  K J Foster; K C Dewbury; A H Griffith; R Wright
Journal:  Br J Radiol       Date:  1980-05       Impact factor: 3.039

7.  Considerations on the pathogenesis of fatty liver.

Authors:  B Lombardi
Journal:  Lab Invest       Date:  1966-01       Impact factor: 5.662

8.  Abdominal obesity and breast cancer risk.

Authors:  D V Schapira; N B Kumar; G H Lyman; C E Cox
Journal:  Ann Intern Med       Date:  1990-02-01       Impact factor: 25.391

9.  Obesity, hormones, and cancer.

Authors:  M A Kirschner; N Ertel; G Schneider
Journal:  Cancer Res       Date:  1981-09       Impact factor: 12.701

10.  Breast-cancer incidence and mortality rates in different countries in relation to known risk factors and dietary practices.

Authors:  G E Gray; M C Pike; B E Henderson
Journal:  Br J Cancer       Date:  1979-01       Impact factor: 7.640

View more
  2 in total

1.  First indicators of relapse in breast cancer: evaluation of the follow-up program at our hospital.

Authors:  Yoshinari Ogawa; Katsumi Ikeda; Tetsuo Izumi; Shiho Okuma; Makoto Ichiki; Tetsuro Ikeya; Jyunya Morimoto; Yukio Nishiguchi; Teruyuki Ikehara
Journal:  Int J Clin Oncol       Date:  2012-03-14       Impact factor: 3.402

2.  Dietary soy protein induces hepatic lipogenic enzyme gene expression while suppressing hepatosteatosis in obese female Zucker rats bearing DMBA-initiated mammary tumors.

Authors:  Reza Hakkak; Ahmed Al-Dwairi; George J Fuchs; Soheila Korourian; Frank A Simmen
Journal:  Genes Nutr       Date:  2012-04-24       Impact factor: 5.523

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.